SCHEMBL5726640

SCHEMBL5726640

CCOC(Cc1ccc(OCCn2c(=O)sc3cc(C(=NO)c4cccc(Cl)c4)ccc32)cc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.63
PPARG P37231 16/20 0.63
PPARD Q03181 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726635 1.00 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL5416979 0.93 PPARA (0.67) PPARAPPARGPPARD
SCHEMBL5429410 0.93 PPARA (0.67) PPARAPPARGPPARD
SCHEMBL5416971 0.93 PPARA (0.67) PPARAPPARGPPARD
SCHEMBL5417890 0.93 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL5417887 0.93 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL5423189 0.93 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL5423193 0.93 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL5727529 0.93 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL5727846 0.93 PPARA (0.66) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1502590-B1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes SERVIER LAB (FR) 2006-12-20 EP claimed
EP-1502590-A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes Les Laboratoires Servier (FR) 2005-02-02 EP claimed
EP-1502590-B1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes SERVIER LAB (FR) 2006-12-20 EP disclosed
EP-1729767-A1 COMBINATION OF A HETEROCYCLIC COMPOUND AND AN ANTIOXIDANT AND USE THEREOF FOR TREATING OBESITY Les Laboratoires Servier (FR) 2006-12-13 EP disclosed
WO-2005099694-A1 COMBINATION OF A HETEROCYCLIC COMPOUND AND AN ANTIOXIDANT AND USE THEREOF FOR TREATING OBESITY LES LABORATOIRES SERVIER (FR) 2005-10-27 WO disclosed
EP-1502590-A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes Les Laboratoires Servier (FR) 2005-02-02 EP disclosed